Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Biotechnology
Mind Medicine Inc (MNMD) Q2 2024 Earnings Call Transcript Highlights: Strong Financial Position and Promising Clinical Developments
Mind Medicine Inc (MNMD) reports significant cash reserves and advances in clinical trials for anxiety and depression treatments. Aug 16, 2024
GuruFocus Research Biotechnology
Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and Strategic Market Expansions
Oncopeptides AB reports a 60% revenue increase and strong cash position, while navigating market access challenges and future profitability plans. Aug 16, 2024
GuruFocus Research Biotechnology
Matinas BioPharma Holdings Inc (MTNB) Q2 2024 Earnings Call Transcript Highlights: Financial Improvements and Strategic Progress Amid Challenges
Matinas BioPharma Holdings Inc (MTNB) reports reduced net loss and increased cash reserves, while facing delays and uncertainties in key projects. Aug 16, 2024